United Therapeutics Corp.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.21B | $5.17B | $894.8M |
| FY2022 | $1.25B | $6.04B | $961.2M |
| FY2023 | $1.18B | $7.17B | $1.21B |
| FY2024 | $920.0M | $7.36B | $1.70B |
| FY2025 | $783.8M | $7.88B | $1.56B |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.21B | $5.17B | $894.8M |
| FY2022 | $1.25B | $6.04B | $961.2M |
| FY2023 | $1.18B | $7.17B | $1.21B |
| FY2024 | $920.0M | $7.36B | $1.70B |
| FY2025 | $783.8M | $7.88B | $1.56B |